{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:24:40Z","timestamp":1762507480114},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T00:00:00Z","timestamp":1535673600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s11886-018-1025-4","type":"journal-article","created":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T08:23:48Z","timestamp":1535703828000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Drug-Coated Balloons: Hope or Hot Air: Update on the Role of Coronary DCB"],"prefix":"10.1007","volume":"20","author":[{"given":"Rafael A.","family":"Meneguz-Moreno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"J.","family":"Ribamar Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Abizaid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,31]]},"reference":[{"issue":"2","key":"1025_CR1","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1161\/01.CIR.96.2.636","volume":"96","author":"DI Axel","year":"1997","unstructured":"Axel DI, Kunert W, Goggelmann C, Oberhoff M, Herdeg C, Kuttner A, et al. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation. 1997;96(2):636\u201345.","journal-title":"Circulation"},{"issue":"4","key":"1025_CR2","doi-asserted-by":"publisher","first-page":"444","DOI":"10.4244\/EIJV8I4A70","volume":"8","author":"P Bondesson","year":"2012","unstructured":"Bondesson P, Lagerqvist B, James SK, Olivecrona GK, Venetsanos D, Harnek J. Comparison of two drug-eluting balloons: a report from the SCAAR registry. EuroIntervention. 2012;8(4):444\u20139.","journal-title":"EuroIntervention."},{"issue":"5","key":"1025_CR3","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1160\/TH10-11-0698","volume":"105","author":"M Joner","year":"2011","unstructured":"Joner M, Byrne RA, Lapointe JM, Radke PW, Bayer G, Steigerwald K, et al. Comparative assessment of drug-eluting balloons in an advanced porcine model of coronary restenosis. Thromb Haemost. 2011;105(5):864\u201372.","journal-title":"Thromb Haemost"},{"issue":"6","key":"1025_CR4","first-page":"730","volume":"7","author":"PW Radke","year":"2011","unstructured":"Radke PW, Joner M, Joost A, Byrne RA, Hartwig S, Bayer G, et al. Vascular effects of paclitaxel following drug-eluting balloon angioplasty in a porcine coronary model: the importance of excipients. Euro Interv. 2011;7(6):730\u20137.","journal-title":"Euro Interv"},{"issue":"37","key":"1025_CR5","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","volume":"35","author":"S Windecker","year":"2014","unstructured":"Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, et al. 2014 ESC\/EACTS guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014;35(37):2541\u2013619.","journal-title":"Eur Heart J"},{"issue":"20","key":"1025_CR6","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1056\/NEJMoa061254","volume":"355","author":"B Scheller","year":"2006","unstructured":"Scheller B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U, et al. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med. 2006;355(20):2113\u201324.","journal-title":"N Engl J Med"},{"issue":"10","key":"1025_CR7","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s00392-008-0682-5","volume":"97","author":"B Scheller","year":"2008","unstructured":"Scheller B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U, et al. Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. Clin Res Cardiol. 2008;97(10):773\u201381.","journal-title":"Clin Res Cardiol"},{"issue":"3","key":"1025_CR8","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.jcin.2012.01.008","volume":"5","author":"B Scheller","year":"2012","unstructured":"Scheller B, Clever YP, Kelsch B, Hehrlein C, Bocksch W, Rutsch W, et al. Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. JACC Cardiovasc Interv. 2012;5(3):323\u201330.","journal-title":"JACC Cardiovasc Interv"},{"issue":"23","key":"1025_CR9","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1161\/CIRCULATIONAHA.108.839282","volume":"119","author":"M Unverdorben","year":"2009","unstructured":"Unverdorben M, Vallbracht C, Cremers B, Heuer H, Hengstenberg C, Maikowski C, et al. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis. Circulation. 2009;119(23):2986\u201394.","journal-title":"Circulation"},{"issue":"8","key":"1025_CR10","doi-asserted-by":"publisher","first-page":"926","DOI":"10.4244\/EIJY14M08_12","volume":"11","author":"M Unverdorben","year":"2015","unstructured":"\u2022 Unverdorben M, Vallbracht C, Cremers B, Heuer H, Hengstenberg C, Maikowski C, et al. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: the three-year results of the PEPCAD II ISR study. EuroIntervention. 2015;11(8):926\u201334. This article demonstrates stability of lesions treated with paclitaxel-DCB throughout 3\u00a0years, in comparison to paclitaxel-DES, regarding treatment of BMS ISR.","journal-title":"EuroIntervention"},{"issue":"4","key":"1025_CR11","first-page":"439","volume":"10","author":"T Adriaenssens","year":"2014","unstructured":"Adriaenssens T, Dens J, Ughi G, Bennett J, Dubois C, Sinnaeve P, et al. Optical coherence tomography study of healing characteristics of paclitaxel-eluting balloons vs. everolimus-eluting stents for in-stent restenosis: the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) randomised clinical trial. Euro Interv. 2014;10(4):439\u201348.","journal-title":"Euro Interv"},{"issue":"14","key":"1025_CR12","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1016\/j.jacc.2013.12.006","volume":"63","author":"F Alfonso","year":"2014","unstructured":"Alfonso F, Perez-Vizcayno MJ, Cardenas A, Garcia Del Blanco B, Seidelberger B, Iniguez A, et al. A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V clinical trial (restenosis intra-stent of bare metal stents: paclitaxel-eluting balloon vs. everolimus-eluting stent). J Am Coll Cardiol. 2014;63(14):1378\u201386.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"1025_CR13","doi-asserted-by":"publisher","first-page":"e003316","DOI":"10.1161\/CIRCINTERVENTIONS.115.003316","volume":"9","author":"L Pleva","year":"2016","unstructured":"\u2022 Pleva L, Kukla P, Kusnierova P, Zapletalova J, Hlinomaz O. Comparison of the efficacy of paclitaxel-eluting balloon catheters and everolimus-eluting stents in the treatment of coronary in-stent restenosis: the treatment of in-stent restenosis study. Circ Cardiovasc Interv. 2016;9(4):e003316. This article reports significantly less 12-month LLL paclitaxel-DCB treatment throughout 3\u00a0years, in comparison to second-generation DES, regarding BMS ISR.","journal-title":"Circ Cardiovasc Interv"},{"issue":"9865","key":"1025_CR14","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0140-6736(12)61964-3","volume":"381","author":"RA Byrne","year":"2013","unstructured":"Byrne RA, Neumann FJ, Mehilli J, Pinieck S, Wolff B, Tiroch K, et al. Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial. Lancet. 2013;381(9865):461\u20137.","journal-title":"Lancet"},{"issue":"2","key":"1025_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-017231","volume":"8","author":"JZ Cai","year":"2018","unstructured":"Cai JZ, Zhu YX, Wang XY, Bourantas CV, Iqbal J, Zhu H, et al. Comparison of new-generation drug-eluting stents versus drug-coated balloon for in-stent restenosis: a meta-analysis of randomised controlled trials. BMJ Open. 2018;8(2):e017231.","journal-title":"BMJ Open"},{"issue":"1","key":"1025_CR16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ancard.2013.07.001","volume":"63","author":"E Puymirat","year":"2014","unstructured":"Puymirat E, Barbato E. Percutaneous revascularization strategies in small-vessel disease. Ann Cardiol Angeiol (Paris). 2014;63(1):28\u201331.","journal-title":"Ann Cardiol Angeiol (Paris)"},{"issue":"1","key":"1025_CR17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/ccd.25485","volume":"84","author":"R Caputo","year":"2014","unstructured":"Caputo R, Leon M, Serruys P, Neumann FJ, Yeung A, Windecker S, et al. Performance of the resolute zotarolimus-eluting stent in small vessels. Catheter Cardiovasc Interv. 2014;84(1):17\u201323.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"5","key":"1025_CR18","first-page":"620","volume":"9","author":"M Unverdorben","year":"2013","unstructured":"Unverdorben M, Kleber FX, Heuer H, Figulla HR, Vallbracht C, Leschke M, et al. Treatment of small coronary arteries with a paclitaxel-coated balloon catheter in the PEPCAD I study: are lesions clinically stable from 12 to 36 months? Euro Interv. 2013;9(5):620\u20138.","journal-title":"Euro Interv"},{"issue":"16","key":"1025_CR19","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1136\/hrt.2010.195057","volume":"96","author":"B Cortese","year":"2010","unstructured":"Cortese B, Micheli A, Picchi A, Coppolaro A, Bandinelli L, Severi S, et al. Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomised clinical trial. The PICCOLETO study. Heart. 2010;96(16):1291\u20136.","journal-title":"Heart"},{"issue":"24","key":"1025_CR20","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1016\/j.jacc.2012.09.020","volume":"60","author":"A Latib","year":"2012","unstructured":"Latib A, Colombo A, Castriota F, Micari A, Cremonesi A, De Felice F, et al. A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: the BELLO (Balloon Elution and Late Loss Optimization) study. J Am Coll Cardiol. 2012;60(24):2473\u201380.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"1025_CR21","first-page":"1132","volume":"8","author":"Azeem Latib","year":"2015","unstructured":"\u2022 Latib A, Ruparelia N, Menozzi A, Castriota F, Micari A, Cremonesi A, et al. 3-year follow-up of the Balloon Elution and Late Loss Optimization study (BELLO). JACC Cardiovasc Interv, 2015. 8(8):1132\u20134. This article reports lower MACE rates at 3\u00a0years with paclitaxel-DCB use in comparison with paclitaxel DES use, treating BMS ISR in small coronary vessels.","journal-title":"JACC: Cardiovascular Interventions"},{"issue":"1","key":"1025_CR22","first-page":"38","volume":"12","author":"JF Lassen","year":"2016","unstructured":"Lassen JF, Holm NR, Banning A, Burzotta F, Lefevre T, Chieffo A, et al. Percutaneous coronary intervention for coronary bifurcation disease: 11th consensus document from the European Bifurcation Club. Euro Interv. 2016;12(1):38\u201346.","journal-title":"Euro Interv"},{"issue":"6","key":"1025_CR23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11886-015-0595-7","volume":"17","author":"JM Lee","year":"2015","unstructured":"Lee JM, Park KW, Koo BK, Kim HS. Stenting of coronary bifurcation lesions: a literature and technical review. Curr Cardiol Rep. 2015;17(6):45.","journal-title":"Curr Cardiol Rep"},{"issue":"8","key":"1025_CR24","first-page":"868","volume":"11","author":"J Berland","year":"2015","unstructured":"Berland J, Lefevre T, Brenot P, Fajadet J, Motreff P, Guerin P, et al. DANUBIO - a new drug-eluting balloon for the treatment of side branches in bifurcation lesions: six-month angiographic follow-up results of the DEBSIDE trial. Euro Interv. 2015;11(8):868\u201376.","journal-title":"Euro Interv"},{"key":"1025_CR25","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.ijcard.2015.04.002","volume":"187","author":"MH Jim","year":"2015","unstructured":"Jim MH, Lee MK, Fung RC, Chan AK, Chan KT, Yiu KH. Six month angiographic result of supplementary paclitaxel-eluting balloon deployment to treat side branch ostium narrowing (SARPEDON). Int J Cardiol. 2015;187:594\u20137.","journal-title":"Int J Cardiol"},{"issue":"7","key":"1025_CR26","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.carrev.2015.07.009","volume":"16","author":"S Worthley","year":"2015","unstructured":"Worthley S, Hendriks R, Worthley M, Whelan A, Walters DL, Whitbourn R, et al. Paclitaxel-eluting balloon and everolimus-eluting stent for provisional stenting of coronary bifurcations: 12-month results of the multicenter BIOLUX-I study. Cardiovasc Revasc Med. 2015;16(7):413\u20137.","journal-title":"Cardiovasc Revasc Med"},{"issue":"Suppl K","key":"1025_CR27","doi-asserted-by":"publisher","first-page":"K125","DOI":"10.4244\/EIJV7SKA21","volume":"7","author":"FX Kleber","year":"2011","unstructured":"Kleber FX, Mathey DG, Rittger H, Scheller B. How to use the drug-eluting balloon: recommendations by the German consensus group. EuroIntervention. 2011;7(Suppl K):K125\u20138.","journal-title":"EuroIntervention"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11886-018-1025-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-018-1025-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-018-1025-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T21:44:38Z","timestamp":1581975878000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11886-018-1025-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,31]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["1025"],"URL":"https:\/\/doi.org\/10.1007\/s11886-018-1025-4","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,31]]},"assertion":[{"value":"31 August 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Rafael A. Meneguz-Moreno, J. Ribamar Costa Jr., and Alexandre Abizaid declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"100"}}